Avricore Health (AVCRF) EPS (Weighted Average and Diluted) (2013 - 2025)
Avricore Health (AVCRF) reported EPS (Weighted Average and Diluted) of -$0.0 for Q3 2025, down 120.89% year-over-year from $0.02 in Q3 2024, and up 20.4% quarter-over-quarter from -$0.0 in Q2 2025.
Avricore Health (AVCRF) EPS (Weighted Average and Diluted) (2013 - 2025) Analysis & Trends
Avricore Health (AVCRF) has 9 years of EPS (Weighted Average and Diluted) data on file, last reported at -$0.0 in Q3 2025.
- EPS (Weighted Average and Diluted) for Q3 2025 came in at -$0.0, down 120.89% year-over-year; the trailing twelve-month figure through Dec 2025 was -$0.01 (down 2346.66% YoY), and the FY2025 annual result was -$0.01, down 85.36% from the prior year.
- EPS (Weighted Average and Diluted) grew to -$0.0 in Q3 2025 per AVCRF's latest filing, from -$0.0 in the prior quarter.
- Over five years, EPS (Weighted Average and Diluted) peaked at $0.0 in Q4 2023 and troughed at -$0.0 in Q2 2025.
- A 4-year average of -$0.0 and a median of -$0.0 in 2022 frame the typical range for EPS (Weighted Average and Diluted).
- The sharpest annual moves came in 2023 and 2025: EPS (Weighted Average and Diluted) jumped 128.28% in 2023, then plunged 1001.85% in 2025.
- A 4-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.0 in 2022, then jumped by 128.28% to $0.0 in 2023, then plunged by 342.06% to -$0.0 in 2024, then tumbled by 120.89% to -$0.0 in 2025.
- Business Quant data shows AVCRF's EPS (Weighted Average and Diluted) at -$0.0 in Q3 2025, -$0.0 in Q2 2025, and -$0.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -0.87 |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 4.43 |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 1.45 |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 3.47 |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 1.20 |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -0.60 |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 1.61 |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 0.87 |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 8.33 |
| 10 | Avricore Health | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.00 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.00 |
| Dec 31, 2020 | -0.01 |
| Dec 31, 2019 | -0.01 |
| Sep 30, 2019 | -0.01 |
| Mar 31, 2019 | -0.01 |
| Sep 30, 2015 | -55,752.30 |
| Sep 30, 2014 | -15,760.80 |
| Sep 30, 2013 | -16,985.00 |